Cocaine seizure in the EU reached record highs in 2017 and the trafficking of synthetic drugs has also increased, according to this year's European Drug Report. A closer look into Berlin's drug help centre shows how drug consumption is linked to mental health. EURACTIV Germany reports.
The European Commission’s much-awaited communication on the environmental impact of pharmaceuticals is at an “advanced stage” but might not be adopted in the near future because of other legislative initiatives on the agenda, an EU official has told EURACTIV.com.
The European Commission’s proposal to add an SPC manufacturing waiver on exports will not damage innovation, as the pharma industry claims, and only intends to support small and medium generic drug companies, according to EU Health Commissioner Vytenis Andriukaitis.
The next EU Health Council on 8 December will discuss the “lack of drug availability in Greece”, amid mounting tensions between the leftist government in Athens and the pharmaceutical companies.
The competition for the European Medicines Agency is not a horse race but the first concrete, effective decision the EU has to make in the wake of Brexit - and one with long-lasting consequences. A responsible yet ambitious mindset is therefore in orde...
Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, ROCHE, a Swiss multinational company, ultimately decided to make the drug available to patients for free.
The European Commission launched on Thursday (12 October) a public consultation on supplementary protection certificates for pharmaceutical products and the so-called Bolar patent research exemption.
Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.